Reproxalap Activity and Estimation of Clinically Relevant Thresholds for Ocular Itching and Redness in a Randomized Allergic Conjunctivitis Field Trial

INTRODUCTION: This clinical trial assessed the activity of reproxalap, a novel reactive aldehyde species modulator, and estimated clinically relevant thresholds for changes in ocular itching and redness in an allergic conjunctivitis field trial. METHODS: This was a randomized, double-masked, vehicle...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavanagh, Bill, Gomes, Paul J., Starr, Christopher E., Nichols, Kelly K., Brady, Todd C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253207/
https://www.ncbi.nlm.nih.gov/pubmed/35585427
http://dx.doi.org/10.1007/s40123-022-00520-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253207/
https://www.ncbi.nlm.nih.gov/pubmed/35585427
http://dx.doi.org/10.1007/s40123-022-00520-z

Ejemplares similares